CGRP-targeting tx are a 1st line option for migraine prevention: An AHS position statement update

Описание к видео CGRP-targeting tx are a 1st line option for migraine prevention: An AHS position statement update

We spoke with Andrew Charles MD, President of the American Headache Society and the first author of "Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update," about this work.

You can access the Free Access manuscript here:
https://headachejournal.onlinelibrary...

Headache publishes original articles on all aspects of head and face pain and is the official journal of the American Headache Society.

Комментарии

Информация по комментариям в разработке

Похожие видео